瑞迈特 (301367)
BMC Medical Co., Ltd.
K-Line Chart
No K-line data available
Company NameBeijing Ruimaite Medical Technology Co., Ltd.
Listing Date2022-11-01
Issue Price119.88RMB
Registered Capital896010k RMB
Legal RepresentativeZhuang Zhi
Registered AddressNo. 110, Building A, Fengyu Office Building, No. 115 Fucheng Road, Haidian District, Beijing
IndustryMedical Devices
Main BusinessManufacturing of medical devices and consumables in the respiratory health field.
Company ProfileBeijing Ruimaite Medical Technology Co., Ltd. was the lead unit of the 2020 Tianjin Key R&D Program's special project 'Research and Development of a High-Flow Humidified Oxygen Therapy System for the COVID-19 Pandemic' under the 'Emergency Prevention and Control of Novel Coronavirus Infection' key initiative. This project was recommended by the Tianjin Science and Technology Bureau to the Ministry of Science and Technology's 'Science and Technology Boosting the Economy 2020' key special project and was approved. In the 2019 Ministry of Science and Technology's 'Digital Diagnosis and Treatment Equipment R&D' key special project, the company was the lead unit for the 'SPAP High-Flow Respiratory Humidification Therapy Device for Complex Respiratory Support' project. In the 2018 Ministry of Science and Technology's 'Research on Prevention and Control of Major Chronic Non-Communicable Diseases' key special project, the company was the responsible unit for the sub-project 'Development of Intelligent Wearable Devices, Diagnosis and Treatment Reminder Terminals, and Non-Invasive Mechanical Ventilation Systems for the Treatment of Severe COPD Acute Exacerbations, Home Management during Stable Periods, and Self-Rehabilitation' under the main project 'Research and Promotion of IoT Technology for Early Screening, Prevention, Treatment, and Respiratory Health Management of COPD'. In the 2017 Ministry of Science and Technology's 'Digital Diagnosis and Treatment Equipment R&D' key special project, the company was a participating unit in the 'Research on a Hierarchical Diagnosis and Treatment System for Digital Integrated Equipment for Sleep Respiratory Diseases' project.
Stock Details
1. Key Indicators
- Total Shares(W): 8960.00
- Circulating A-Shares(W): 6994.36
- Earnings Per Share(RMB): 2.0252
- Net Assets Per Share(RMB): 33.2621
- Operating Revenue(W RMB): 80821.80
- Total Profit(W RMB): 21032.76
- Net Profit Attributable to Parent(W RMB): 18000.83
- Net Profit Growth Rate(%): 43.87
- Weighted Return on Equity(%): 6.2000
- Operating Cash Flow Per Share(RMB): 0.9860
- Undistributed Profit Per Share(RMB): 12.7334
- Capital Reserve Per Share(RMB): 19.6005
2. Main Business
The main business covers:
- Manufacturing of medical equipment and consumables in the respiratory health field
3. Company Basic Information
- Company Name: BMC Medical Co., Ltd.
- Listing Date: 2022-11-01
- Industry: Medical and Pharmaceutical - Medical Devices (Special Equipment Manufacturing)
- Address: Room 10, 17th Floor, Beijing Huiya Building, Building 4, No. 16 Lize Road, Fengtai District, Beijing
- Website: www.bmc-medical.com
- Company Profile：On August 8, 2016, Yihe Limited held a board meeting and passed a resolution to approve the overall change of Yihe Limited into a joint-stock company; agreed to use June 30, 2016 as the restructuring base date, and based on the audited net assets, the original shareholders of the company subscribed their respective contributions by converting net assets into shares, with the portion of net assets exceeding the share capital recorded as capital reserve; after the restructuring, the company's registered capital was 3,133,825.00 yuan, with a total of 3,133,825.00 shares, each with a par value of 1 yuan;
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Zhuhai Hehuan Investment Center (Limited Partnership) | General Legal Person | 1063.25 | 18.81 |
| 2 | Nengjin Co., Ltd. | General Legal Person | 435.24 | 7.70 |
| 3 | Shenzhen Maixing Investment Management Center (Limited Partnership) - Shanghai Shengmin Venture Capital Partnership (Limited Partnership) | General Legal Person | 359.61 | 6.36 |
| 4 | Guosen Securities Co., Ltd. | Broker | 135.48 | 2.40 |
| 5 | China Universal Healthcare Mixed Securities Investment Fund | Fund | 129.53 | 2.29 |
| 6 | Yinhua Fund - China Life Insurance Co., Ltd. - Universal A - Yinhua Fund Guoshou Shares Growth Equity Portfolio Universal A Available-for-sale Single Asset Management Plan | Asset Management Plan | 87.64 | 1.55 |
| 7 | Ruizhong Life Insurance Co., Ltd. - Own Funds | Insurance | 75.74 | 1.34 |
| 8 | Yuansin Yongfeng Pharmaceutical Health Mixed Securities Investment Fund Class A | Fund | 66.00 | 1.17 |
| 9 | Yuansin Yongfeng Juyou Equity Securities Investment Fund Class A | Fund | 56.87 | 1.01 |
| 10 | Yuansin Yongfeng Xingyuan Flexible Allocation Mixed Securities Investment Fund Class A | Fund | 26.15 | 0.46 |
5. Concept Sectors
- Intelligent Machines
- Margin Trading & Short Selling
- High-Performance Stocks
- Heavily Held by Brokers
- Intended Reduction
- Intensive Research
- Fund Reduction
- Tencent Ji'an
- Innovation and Entrepreneurship
- Chuang Medicine
- Small-Cap Innovation Board
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information